Colorized scanning electron micrograph of a cell (orange) infected with UK B.1.1.7 variant SARS-CoV-2 virus particles (green), isolated from a patient sample. Image captured at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland.
(NIAID)
Variants of the original SARS-CoV-2 are now in wide circulation. That means the third wave of COVID-19 has come with new questions about the variants, their effects and what might come next.
If you’ve already had the coronavirus and recovered, you might be tempted to give the vaccine a pass. A scientist explains why the shot offers the best protection against future infection.
Antibodies (white) binding to a coronavirus (red and orange).
Kateryna Kon/Shutterstock
So far, most vaccines in the US are mRNA vaccines. These represent a new technology and are likely to take over the vaccine world. But how do they work? What are their weaknesses? Five experts explain.
New treatments target different stages of COVID-19, including before patients become sick enough to need a hospital.
Juan Monino via Getty Images
A year after it became clear that COVID-19 was becoming a pandemic, there is still no cure, but doctors have several innovative treatments. Some are keeping patients out of the hospital entirely.
Antibodies (blue) neutralising SARS-CoV-2 (orange), the virus that causes COVID-19.
Kateryna Kon/Shutterstock
Researchers don’t fully understand the composition of breast milk and its benefits. Beyond nutrition, it contains enzymes, hormones and the mother’s antibodies — including antibodies for COVID-19.
Study shows that the Novavax vaccine is effective against the dominant variant of COVID-19 in South Africa.
Jakub Porzycki/NurPhoto via Getty Images
The results indicate that the vaccine efficacy in the UK was 89% for individuals who received at least two doses of vaccine. In South Africa, the vaccine efficacy was 60% in people without HIV.
Neutralizing antibodies attach to the tips of the spike proteins of the SARS CoV-2 virus.
David Goodsell/ProteinDatabase
A biologist explains what proteins do in viruses, how they interact with human cells, how the vaccine delivers mRNA into the cell and how antibodies protect us.
With vaccine shortages looming, experts are debating whether it is important to receive two doses or whether it’s better to give one dose to more people and give a second when the supply is better.
Some have suggested the US allow healthy people to return to normal life, catch the coronavirus and get the population to herd immunity. The science says this plan is doomed to fail from the start.
Are antibodies that attack a patient’s own organs contributing to severe forms of COVID-19? A new study suggests specific antibody tests that may reveal the answer.
Vaccines work by teaching your immune system about new viruses. Your immune cells are very clever – they will remember what they learnt, and protect you if you encounter that virus in the future.
A lab technician holds a vial of a COVID-19 vaccine candidate during testing at the Chula Vaccine Research Center, run by Chulalongkorn University in Bangkok, Thailand on May 25, 2020.
(AP Photo/Sakchai Lalit)
Will a vaccine for COVID-19 be safe? Animal testing, human clinical trials and post-approval surveillance give us good grounds to believe that a future approved vaccine will work and be safe.